| 24.20 |  -1.94 / -7.42% |
Data as of 4:00pm ET | Day’s Change |
| 24.17 | -0.03 / -0.12% |
Volume: 5,000.00 |
| Previous close | 26.14 |
| Today’s open | 26.27 |
| Day’s range | 23.82 - 26.27 |
| Volume | 2,215,064 |
| Average volume (3 months) | 326,523 |
| Market cap | $724.7M |
| Dividend yield | -- |
| Earnings growth (last year) | +17.05% |
| Earnings growth (this year) | +17.71% |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | +18.44% |
| P/E ratio | 15.6 |
| Price/Sales | 1.16 |
| Price/Book | 3.19 |
| Today’s change | Today’s % change | |
|---|---|---|
| KERXKeryx Biopharmaceuti... | +0.18 | +2.22% |
| NXTMNxstage Medical Inc | +0.45 | +4.17% |
| EXELExelixis Inc | +0.29 | +6.43% |
| SGYPSynergy Pharmaceutic... | -1.23 | -16.99% |
| Next reporting date | June 6, 2013 |
| EPS forecast (this quarter) | $0.41 |
| Annual revenue (last year) | $661.7M |
| Annual profit (last year) | $42.2M |
| Net profit margin | 6.37% |
Sector Health Services |
Industry Services to the Health Industry |
Chairman, President & Chief Executive Officer Marc D. Grodman, MD |
Chief Operating Officer, Director & Executive VP Howard Dubinett |
Corporate headquarters Elmwood Park, New Jersey |
.
